Cata-Kor and Reus Research searches can refer to different formulations and older reviews. The current product and its exact ingredient panel matter more than the shared NAD branding.
An October 2025 National Advertising Division decision provides useful context, but it must be described accurately: it supported some testing claims while recommending changes to other claims. It was not an FDA product approval or a finding that every claim was false.
Cata-Kor and Reus Research searches can refer to different formulations and older reviews. The current product and its exact ingredient panel matter more than the shared NAD branding.
Which version is being discussed?
The official NAD Core listing and Advanced products should be compared separately. Older NR product reviews are not evidence for a newer direct-NAD formula. Ask the seller which current version ships and whether the reviews on a listing refer to that same formulation.
What did the advertising review address?
BBB National Programs reported findings concerning ingredient amounts, purity wording, health claims, influencer disclosures, and the combination of reviews from substantially different products. It supported specified third-party testing claims but recommended modification or discontinuation of others. Reus said it would comply. This is an advertising self-regulation decision; it does not measure a current retail bottle's contents.
Why does liposomal blend weight matter?
The decision discussed whether consumers could confuse a liposomal ingredient weight with the amount of NAD itself. For any current product, ask what the stated milligrams include. A carrier plus active ingredient is not necessarily the same weight as the active alone. This is a useful question for all liposomal brands, not only Cata-Kor.
What evidence should a buyer request now?
Obtain the present label and a matching lot report, then ask for human evidence on the finished product's health claims. A report demonstrating identity or content does not establish improved energy or longevity. The liposomal guide separates quality testing from delivery and outcome evidence.
Our assessment
Use the dated advertising findings as context and verify the current offer independently. Do not transfer older NR testimonials to a different product, and do not rely on a competitor's summary alone. The brand directory and supplement comparison provide other formulas to investigate without inventing a clinical ranking.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- Cata-Kor: NAD Core 250 mg Manufacturer listing; confirm exact version and current label.
- BBB National Programs: Reus advertising decision, October 2025 Primary product or publisher source; scope and verification limits are described in the article. Checked September 18, 2026.
- FDA: questions and answers on dietary supplements Regulatory categories and limits of premarket review.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.